Company · CIK 0001369568 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
CATALYST PHARMACEUTICALS, INC. · CPRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Brian ElsberndChief Legal Officer | 242,501 | $31.50 | $7,638,782 | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | David S TierneyDirector | 383,314 | $31.50 | $12,074,391 | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Steve MillerChief Op. & Scientific Officer | 1,093,803 | $31.50 | $34,454,795 | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Tamar ThompsonDirector | 3,773 | $31.50 | $118,850 | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Gregg RussoChief HR Officer | 476 | $31.50 | $14,994 | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Patrick J McEnanyDirector | 4,171,559 | $31.50 | $131,404,109 | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Donald A DenkhausDirector | 498,773 | $31.50 | $15,711,350 | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Jeffrey Del CarmenChief Commercial Officer | 14,337 | $31.50 | $451,616 | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Preethi SundaramChief Strategy Officer | 54,804 | $31.50 | $1,726,326 | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Richard J DalyPresident and CEO, Director | 271,266 | $31.50 | $8,544,879 | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | William T. AndrewsChief Medical Officer | 2,309 | $31.50 | $72,734 | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Molly HarperDirector | 3,694 | $31.50 | $116,361 | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Michael Wayne KalbChief Financial Officer | 13,665 | $31.50 | $430,448 | 0 | — | |
| Jun 3, 2026 FMForm 4 → | Jun 5, 5:00 pm EDT | William T. AndrewsChief Medical Officer | 3,795 | — | — | 2,309 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Brian ElsberndChief Legal Officer | 956,142 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Daniel J. CurranDirector | 63,583 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | David S TierneyDirector | 178,163 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Steve MillerChief Op. & Scientific Officer | 1,471,649 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Tamar ThompsonDirector | 119,663 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Gregg RussoChief HR Officer | 71,786 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Patrick J McEnanyDirector | 1,851,948 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Donald A DenkhausDirector | 178,163 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Jeffrey Del CarmenChief Commercial Officer | 1,036,846 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Preethi SundaramChief Strategy Officer | 798,437 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Richard J DalyPresident and CEO, Director | 2,618,539 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | William T. AndrewsChief Medical Officer | 265,084 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Molly HarperDirector | 127,163 | — | — | 0 | — | |
| Jul 15, 2026 DForm 4 → | Jul 17, 4:15 pm EDT | Michael Wayne KalbChief Financial Officer | 632,903 | — | — | 0 | — | |
| Jun 3, 2025 MForm 4 → | Jun 5, 2026, 5:00 pm EDT | William T. AndrewsChief Medical Officer | 3,052 | — | — | 240,195 | — | late |